ASRS 2019 Street Team: Raj K. Maturi, MD

Article
Conference|ASRS

ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process

Raj K. Maturi, MD, discusses phase II data from the abicipar Phase II MAPLE Trial for patients with AMD at the 2019 annual ASRS conference.

Recent Videos
Marion Munk, MD, PhD, presenting slides
Marion Munk, MD, PhD, presenting slides
Related Content
Adverum Biotechnologies shares positive 52-week LUNA and 4-year OPTIC results

Adverum Biotechnologies shares positive 52-week LUNA and 4-year OPTIC results

Sydney M Crago
November 21st 2024
Article
Putting in practice retina innovations amid a pandemic

Putting in practice retina innovations amid a pandemic

Alex Delaney-Gesing
August 28th 2020
Podcast
AlloVir, Inc. enters definitive merger agreement to combine with Kalaris Therapeutics

AlloVir, Inc. enters definitive merger agreement to combine with Kalaris Therapeutics

Sydney M Crago
November 18th 2024
Article
EyePod

ASRS 2020: Evaluating 3-year-recurrence rate in non-infectious posterior segment uveitis post-FAi

Alex Delaney-Gesing
July 29th 2020
Podcast
FDA authorizes marketing of Valeda Light Delivery System for treatment of patients with dry AMD

FDA authorizes marketing of Valeda Light Delivery System for treatment of patients with dry AMD

Sydney M Crago
November 12th 2024
Article
FDA clears investigational new drug (IND) application for HG202 by HuidaGene Therapeutics

FDA clears investigational new drug (IND) application for HG202 by HuidaGene Therapeutics

Sydney M Crago
November 12th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.